Annual Reports

 
Quarterly Reports

 
8-K

  • 8-K (Nov 9, 2009)
  • 8-K (Sep 28, 2009)
  • 8-K (Jul 29, 2009)
  • 8-K (Jul 7, 2009)
  • 8-K (Jun 4, 2009)
  • 8-K (May 13, 2009)

 
Other

Aspect Medical Systems 8-K 2005

Documents found in this filing:

  1. 8-K
  2. Ex-99.1
  3. Ex-99.1
e8vk
 

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 12, 2005
     
Aspect Medical Systems, Inc.
(Exact Name of Registrant as Specified in Charter)
 
         
Delaware   000-24663   04-2985553
(State or Other Juris-
diction of Incorporation
  (Commission
File Number)
  (IRS Employer
Identification No.)
 
     
141 Needham Street    
Newton, Massachusetts   02464-1505
(Address of Principal Executive Offices)   (Zip Code)
 
Registrant’s telephone number, including area code: (617) 559-7000

     
 
(Former Name or Former Address, if Changed Since Last Report)
 
     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 


 

Item 3.01      Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
     On September 28, 2005, Aspect Medical Systems, Inc. (the “Company”) reported the resignation of Richard J. Meelia from the Company’s board of directors (the “Board”). Mr. Meelia was a member of the Board’s Audit Committee and Chairman of the Board’s Compensation Committee. On October 12, 2005, the Company received a letter from The Nasdaq Stock Market, Inc. indicating that the Company is not in compliance with the Audit Committee composition requirement for continued listing set forth in Marketplace Rule 4350(d)(2)(A) as a result of having only two independent members instead of the three independent members required by such rule. It is the Company’s intention to be compliant prior to the earlier of its next annual shareholders’ meeting or September 22, 2006, the expiration of the cure period as provided under Marketplace Rule 4350(d)(4).
Item 9.01      Financial Statements and Exhibits
(c)   Exhibits
 
    See Exhibit Index attached hereto.
SIGNATURE
     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
Date: October 14, 2005  Aspect Medical Systems, Inc.
 
 
  By:   /s/ Michael Falvey    
    Michael Falvey   
    Chief Financial Officer   

 


 

         
EXHIBIT INDEX
     
Exhibit No.   Description
 
Exhibit 99.1
  Press release dated October 14, 2005

 

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki